RareAgent: Self-Evolving Reasoning for Drug Repurposing in Rare Diseases
Computational drug repurposing for rare diseases is especially challenging when no prior associations exist between drugs and target diseases. Therefore, knowledge graph completion and message-passing GNNs have little reliable signal to learn and propagate, resulting in poor performance. We present RareAgent, a self-evolving multi-agent system that reframes this task from passive pattern recognition to active evidence-seeking reasoning. RareAgent organizes task-specific adversarial debates in which agents dynamically construct evidence graphs from diverse perspectives to support, refute, or entail hypotheses. The reasoning strategies are analyzed post hoc in a self-evolutionary loop, producing textual feedback that refines agent policies, while successful reasoning paths are distilled into transferable heuristics to accelerate future investigations. Comprehensive evaluations reveal that RareAgent improves the indication AUPRC by 18.1% over reasoning baselines and provides a transparent reasoning chain consistent with clinical evidence.
Code (0)
등록된 구현이 없습니다.
Tasks
Knowledge Graph CompletionSimilar Papers 제목 키워드 기반
Conversational No-code, Multi-agentic Disease Module Identification and Drug Repurposing Prediction with ChatDRex
Repurposing approved drugs offers a time-efficient and cost-effective alternative to traditional drug development. However, in silico prediction of repurposing candidates is challenging and requires the effective collabo…
Integrating Logical Rules Into Neural Multi-Hop Reasoning for Drug Repurposing
The graph structure of biomedical data differs from those in typical knowledge graph benchmark tasks. A particular property of biomedical data is the presence of long-range dependencies, which can be captured by patterns…
Link Predictionreinforcement-learningReinforcement Learning (RL)When deep learning meets causal inference: a computational framework for drug repurposing from real-world data
Drug repurposing is an effective strategy to identify new uses for existing drugs, providing the quickest possible transition from bench to bedside. Existing methods for drug repurposing that mainly focus on pre-clinical…
Causal InferenceDeep learning for drug repurposing: methods, databases, and applications
Drug development is time-consuming and expensive. Repurposing existing drugs for new therapies is an attractive solution that accelerates drug development at reduced experimental costs, specifically for Coronavirus Disea…
Deep LearningDrugCLIP: Contrastive Drug-Disease Interaction For Drug Repurposing
Bringing a novel drug from the original idea to market typically requires more than ten years and billions of dollars. To alleviate the heavy burden, a natural idea is to reuse the approved drug to treat new diseases. Th…
Contrastive Learning